Medivation Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
JMP Securities Downgrades Medivation (MDVN) to Market Perform
August 10, 2016 7:20 AM EDTJMP Securities downgraded Medivation (NASDAQ: MDVN) from Market Outperform to Market Perform and removed its price target (prior $73).
For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.
Shares of Medivation closed at $63.45 yesterday.
... MoreMedivation (MDVN) PT Lifted to $53 at BMO Capital
August 10, 2016 7:10 AM EDTBMO Capital analyst Do Kim raised estimates and its price target on Medivation (NASDAQ: MDVN) to $53.00 but maintained a Market Perform rating.
Kim commented, :We are incrementally more positive on MDVN following 2Q16 earnings, as underlying Xtandi trends improve, particularly treatment... More
Medivation (MDVN) Tops Q2 EPS by 2c, Affirms Guidance
August 9, 2016 4:15 PM EDTMedivation (NASDAQ: MDVN) reported Q2 EPS of $0.29, $0.02 better than the analyst estimate of $0.27. Revenue for the quarter came in at $206 million versus the consensus estimate of $212.74 million.... More
